Survival and Treatment Patterns in Stage III Inflammatory Breast Cancer

09 Apr 20264 min read0 viewsJournal Feed

GIST

This cohort study compares breast cancer–specific survival and overall survival between patients with inflammatory breast cancer (IBC) and non-IBC by tumor subtype, and examines trends in trimodality therapy use and survival over time.

Clinical Editorial

Summary

JAMA Network Open published a clinical update in Research Highlights on 09 Apr 2026.

The item focuses on Survival and Treatment Patterns in Stage III Inflammatory Breast Cancer.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Effects of traditional Chinese exercises for upper-limb dysfunction following breast cancer surgery: protocol for a systematic review and meta-analysis

Research Highlights • 18 May 2026

Social disparities in the frequency and severity of triple-negative breast cancer at diagnosis in a university hospital in Paris, France: confronting race and ethnic blindness

Research Highlights • 13 May 2026

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10)

Research Highlights • 13 May 2026

Plasma small-extracellular vesicles’ proteomic signature in neoadjuvant chemotherapy–naïve breast cancer patients

Research Highlights • 05 May 2026

Med News TodayRelated by Conditionbreast cancer

How to know you're in perimenopause and how to manage it: OB-GYN tips

Research Highlights • 07 May 2026

When Time Matters in De Novo Metastatic Breast Cancer

Research Highlights • 23 Apr 2026

Feed Metadata

Source

JAMA Network Open